Kornitzer Capital Management Inc. KS Trims Stake in Steris PLC (NYSE:STE)

Kornitzer Capital Management Inc. KS reduced its position in shares of Steris PLC (NYSE:STE) by 25.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,273 shares of the medical equipment provider’s stock after selling 40,322 shares during the period. Kornitzer Capital Management Inc. KS owned approximately 0.14% of Steris worth $17,234,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Squar Milner Financial Services LLC grew its stake in shares of Steris by 225.9% in the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 122 shares in the last quarter. Ropes Wealth Advisors LLC purchased a new position in Steris in the second quarter worth approximately $26,000. Quest Capital Management Inc. ADV purchased a new position in Steris in the third quarter worth approximately $26,000. Evolution Wealth Advisors LLC purchased a new position in Steris in the second quarter worth approximately $27,000. Finally, Krane Funds Advisors LLC purchased a new position in Steris in the second quarter worth approximately $27,000. Hedge funds and other institutional investors own 88.11% of the company’s stock.

Separately, ValuEngine lowered shares of Steris from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $148.20.

Shares of NYSE:STE traded up $0.17 during trading on Friday, reaching $145.36. The stock had a trading volume of 12,815 shares, compared to its average volume of 445,755. The business has a fifty day moving average price of $142.14 and a 200-day moving average price of $143.00. The company has a quick ratio of 1.87, a current ratio of 2.41 and a debt-to-equity ratio of 0.37. The stock has a market cap of $12.38 billion, a P/E ratio of 29.75 and a beta of 0.88. Steris PLC has a fifty-two week low of $99.14 and a fifty-two week high of $156.66.

Steris (NYSE:STE) last posted its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Steris had a net margin of 11.59% and a return on equity of 14.28%. The business had revenue of $736.84 million during the quarter, compared to analyst estimates of $717.79 million. During the same quarter in the previous year, the business posted $1.10 earnings per share. The company’s revenue was up 8.5% on a year-over-year basis. As a group, equities analysts forecast that Steris PLC will post 5.61 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Tuesday, November 26th will be paid a dividend of $0.37 per share. The ex-dividend date of this dividend is Monday, November 25th. This represents a $1.48 annualized dividend and a yield of 1.02%. Steris’s dividend payout ratio is currently 30.27%.

In other news, VP John Adam Zangerle sold 1,000 shares of the company’s stock in a transaction on Friday, October 4th. The shares were sold at an average price of $142.15, for a total value of $142,150.00. Also, VP Renato Tamaro sold 2,065 shares of the company’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $153.15, for a total transaction of $316,254.75. The disclosure for this sale can be found here. 2.36% of the stock is owned by insiders.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Read More: What is Liquidity?

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply